BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7900617)

  • 1. Time-series analysis of long-term ambulatory myocardial ischemia: effects of beta-adrenergic and calcium channel blockade.
    Lambert CR; Raymenants E; Pepine CJ
    Am Heart J; 1995 Apr; 129(4):677-84. PubMed ID: 7900617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta-adrenergic blockade defined by time series analysis on circadian variation of heart rate and ambulatory myocardial ischemia.
    Lambert CR; Coy K; Imperi G; Pepine CJ
    Am J Cardiol; 1989 Oct; 64(14):835-9. PubMed ID: 2801549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS).
    Andrews TC; Fenton T; Toyosaki N; Glasser SP; Young PM; MacCallum G; Gibson RS; Shook TL; Stone PH
    Circulation; 1993 Jul; 88(1):92-100. PubMed ID: 8319361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of time series analysis to circadian rhythms: effect of beta-adrenergic blockade upon heart rate and transient myocardial ischemia.
    Coy KM; Imperi G; Lambert CR; Pepine CJ
    Am J Cardiol; 1990 Nov; 66(16):22G-24G. PubMed ID: 2239708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rewards in practice from chrono-meta-analyses 'recycling' heart rate, ectopy, ischemia and blood pressure information.
    Halberg F; Cornélissen G; Otsuka K; Watanabe Y; Wood MA; Lambert CR; Zaslavskaya R; Gubin D; Yuryevna Petukhova E; Delmore P; Bakken E
    J Med Eng Technol; 1997; 21(5):174-84. PubMed ID: 9350598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
    Deedwania PC; Pool PE; Thadani U; Eff J
    Am J Cardiol; 1997 Aug; 80(4):421-5. PubMed ID: 9285652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta-blockade on heart rate variability in patients with coronary artery disease.
    Niemelä MJ; Airaksinen KE; Huikuri HV
    J Am Coll Cardiol; 1994 May; 23(6):1370-7. PubMed ID: 8176095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.
    Nadazdin A; Davies GJ
    Am Heart J; 1994 Feb; 127(2):312-7. PubMed ID: 8296698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
    Pratt CM; McMahon RP; Goldstein S; Pepine CJ; Andrews TC; Dyrda I; Frishman WH; Geller NL; Hill JA; Morgan NA; Stone PH; Knatterud GL; Sopko G; Conti CR
    Am J Cardiol; 1996 Jun; 77(15):1302-9. PubMed ID: 8677870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chlorthalidone and diltiazem on myocardial ischemia in elderly patients with hypertension and coronary artery disease.
    Serro-Azul JB; de Paula RS; Gruppi C; Pinto L; Pierri H; Nussbacher A; Gebara O; Moffa P; Pereira-Barreto AC; Wajngarten M
    Arq Bras Cardiol; 2001 Apr; 76(4):268-72. PubMed ID: 11323730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
    Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
    Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease.
    Imperi GA; Lambert CR; Coy K; Lopez L; Pepine CJ
    Am J Cardiol; 1987 Sep; 60(7):519-24. PubMed ID: 3630934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
    Deanfield JE; Detry JM; Sellier P; Lichtlen PR; Thaulow E; Bultas J; Brennan C; Young ST; Beckerman B;
    J Am Coll Cardiol; 2002 Sep; 40(5):917-25. PubMed ID: 12225716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release diltiazem reduces myocardial ischemic episodes in end-stage renal disease: a double-blind, randomized, crossover, placebo-controlled trial.
    Cice G; Di Benedetto A; D'Andrea A; D'Isa S; Ferrara L; Russo PE; Iacono A; Calabrò R
    J Am Soc Nephrol; 2003 Apr; 14(4):1006-11. PubMed ID: 12660335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand.
    Parker JD; Testa MA; Jimenez AH; Tofler GH; Muller JE; Parker JO; Stone PH
    Circulation; 1994 Feb; 89(2):604-14. PubMed ID: 8313548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day-to-day variability of the long-term fractal component of heart rate variability (beta) and the effect of an antianginal agent in patients with silent myocardial ischemia.
    Takase B; Akima T; Satomura K; Ohsuzu F; Mastui T; Ishihara M; Kurita A
    Biomed Pharmacother; 2004 Oct; 58 Suppl 1():S123-8. PubMed ID: 15754850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs diltiazem) in patients with stable angina pectoris.
    Brouwer J; Viersma JW; van Veldhuisen DJ; Man in 't Veld AJ; Sijbring P; Haaksma J; Dijk WA; Lie KI
    Am J Cardiol; 1995 Oct; 76(11):759-63. PubMed ID: 7572650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
    Davies RF; Habibi H; Klinke WP; Dessain P; Nadeau C; Phaneuf DC; Lepage S; Raman S; Herbert M; Foris K
    J Am Coll Cardiol; 1995 Mar; 25(3):619-25. PubMed ID: 7860905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST).
    Pepine CJ; Cohn PF; Deedwania PC; Gibson RS; Handberg E; Hill JA; Miller E; Marks RG; Thadani U
    Circulation; 1994 Aug; 90(2):762-8. PubMed ID: 8044945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.